Research Article
BibTex RIS Cite

TÜRKİYE’NİN DOĞU BÖLGESİNDE 25-HİDROKSİ VİTAMİN SEVİYESİ İLE DİSLİPİDEMİ VE İNSÜLİN REZİSTASINI ARASINDAKİ İLİŞKİ

Year 2018, Volume: 51 Issue: 2, 90 - 97, 29.08.2018

Abstract

Amaç:
D vitamini eksikliği ve yetersizliğinin birçok kronik hastalık ile ilişkili
olduğu kabul edilmektedir.
D vitamini, dislipidemi ve insülin
direnci arasındaki ilişki, ilgili hastalıkların erken teşhisi ve tedavisini
sağlayabileceğinden, bu çalışmada D vitamini düzeyleri ile dislipidemi ve
insülin direnci arasındaki ilişkiyi araştırmayı amaçladık.



Gereç
ve yöntemler:
Çalışma 249 sağlıklı kişi ile
gerçekleştirilmiştir. Vitamin D dahil olmak üzere laboratuvar testleri yapıldı.
İnsülin direnci, homeostaz model değerlendirme- insülin direnci indeksi ile
hesaplandı. Ayrıca çeşitli vitamin D düzeyleri ile yaş, cinsiyet, glikoz ve
lipit parametreleri ile insülin direnci arasındaki ilişkiyi araştırdık.



Bulgular:
Katılımcıların D vitamini düzeyi erkeklerde  kadınlara göre daha yüksekti. Vitamin D
seviyeleri yaş arttıkça azaldı. Katılımcıların% 3.6'sında normal D vitamini
düzeyleri,% 14.5'inde yetersizlik, % 45.0'ında eksiklik, % 36.9'unda ciddi
eksiklik saptandı.  İnsülin direnci,
ciddi yetersizliği olanların % 57.6'sında, yetersizliği olanların% 22.3'ünde ve
eksikliği olanların% 8.3'ünde saptandı. Normal D vitamini seviyeleri olanların
hiçbiri insülin direncine sahip değildir. D vitamini grupları arasında lipid
parametresi değerleri açısından anlamlı fark bulunmadı. D vitamini azaldıkça
açlık kan şekeri ve insülin değerleri arttı.



Sonuç:
 Sonuç olarak,  D vitamini, dislipidemi ve insülin direnci
birbirinden bağımsız olarak kabul edilemez. D vitamini taraması ile eksik
bulunanlar için erken müdahaleler  metabolik
sendrom, dislipidemi, diyabet ve obezite gibi diğer hastalıkları önleyebilir.



 

References

  • 1.Holick MF. Vitamin D: a D-lightful health perspective. Nutr Rev. 2008;66: 182-194.2.Lind L, Pollare T, Hvarfner A, Lithell H, Sorensen OH, Ljunghall S. Longterm treatment with active vitamin D (alphacalcidol) in middle-aged men with impaired glucose tolerance. Effects on insulin secretion and sensitivity, glucosetolerance and blood pressure. Diabetes Res. 1989;11:141-147.3.Bischoff-Ferrari H, Giovannucci E, Willett S. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006;84: 18–28.4.Wacker M, Holick MF. Vitamin D-Effects on Skeletal and Extraskeletal Health and the Need for Supplementation. Nutrients 2013;5: 111-148.5.Uçar F, Taşlıpınar MY, Soydaş AÖ, Özcan N. 25-OH vitamin D levels in patients who addmitted to Ankara Etlik Specialized Training Research. Eur J Basic Med Sci. 2012;2: 12-15.6.Bloomgarden ZT. Insulin resistance concepts. Diabetes Care. 2007;30:1320-1326.7.Onat A, Ayhan E, Hergenç G, Can G, Barlan MM. Smoking inhibits visceral fat accumulation in Turkish women: relation of visceral fat and body fat mass to atherogenic dyslipidemia, inflammatory markers, insulin resistance, and blood pressure. Metabolism. 2009;58:963-970.8.Cade C, Norman AW. Rapid normalization/ stimulation by 1,25dihydroxyvitamin D3 of insulin secretion and glucose tolerance in the vitamin D– deficient rat. Endocrinology. 1987;120:1490 –1497.9.Boucher, BJ, Mannan N, Noonan K, Hales CN, Evans SJ. Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia. 1995; 38:1239-124510.Hollick MF, Krane SM. Introduction to Bone and Mineral Metabolism, in Harrison’s Principles of Internal Medicine. 15th ed, McGraw Hill Companies; 2001: p.2198–2201.11.Keskin M, Kurdoğlu S. Homeostasis Model Assessment Is More Reliable Than the Fasting Glucose/Insulin Ratio and Quantitative Insulin Sensitivity Check Index for Assessing Insulin Resistance Among Obese Children and Adolescents. Pediatrıcs. 2005; 115:500-503.12.Holick MF. Vitamin D Deficiency, Medical Progress. The New England Journal Of Medicine. 2007;357: 266–281.13.Song BM, Kim HC, Choi DP, Oh SM, Suh I. Association between Serum 25-Hydroxyvitamin D Level and Insulin Resistance in a Rural Population. Yonsei Med J. 2014;55:1036-1041.14.Olmez D, Bober E, Buyukgebiz A, Cimrin D. The frequency of vitamin D insufficiency in healthy female adolescents. Acta Paediatr. 2006;95:1266-1269.15.Çizmecioglu FM, Etiler N, Görmüş U, Hamzaoglu H, Hatun Ş. Hypovitaminosis D in Obese and Overweight Schoolchildren. J Clin Res Ped Endo. 2008;1:89–96. 16. Cimbek A, Gürsoy G, Kılıç Z, Acar Y, Demirbaş B. Serum hydroxy vitamin D3 levels in type 2 diabetic patients. Med J Ank Hosp. 2012; 45:14-19.17. Evrim N, Atalay E, Gursoy G, Bayram M, Salman RB. Relationship between levels of vitamin D and metabolic syndrome parameters in patients with metabolic syndrome and healthy individuals. Clinics of Turkey J Endocrinol. 2016:11: 36-45. 18. Koshiyama H, Ikeda H, Honjo S, Nakamura Y, Tanaka K, Tsugawa N et al. Hypovitaminosis D is frequent in Japanese subjects with type 2 diabetes. Diabetes Res Clin Pract. 2007;76:470-471.19. Hyppönen E, Power C. Vitamin D status and glucose homeostasis in the 1958 British birth cohort: the role of obesity. Diabetes Care. 2006;29:2244-2246.20.Tahrani AA, Ball A, Shepherd L, Rahim A, Jones AF, Bates A. The prevalence of vitamin D abnormalities in South Asians with type 2 diabetes mellitus in the UK. Int J Clin Pract. 2010;64:351-355.21. Farouhi NG, Ye Z, Rickard AP, Khaw KT, Luben R, Langenberg C et al. Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European prospective investigation into cancer (EPIC)-Norfolk color and updated meta-analysis of prospective studies. Diabetologia. 2012;55:2173–2182. 22. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004;79:820–825. 23. Tsur A, Feldman BS, Feldhammer I, Hoshen MB, Leibowitz G, Balicer RD. Decreased serum concentrations of 25-hydroxycholecalciferol are associated with increased risk of progression to impaired fasting glucose and diabetes. Diabetes Care. 2013;36:1361–1367. 24. Scragg R, Sowers M, Bell C. Serum 25 hydroxy vitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabates Care. 2004; 27:2813-2818. 25. Need AG, O’Loughlin PD, Horowitz M, Nordin BE: Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxy vitamin D in postmenopausal women. Clin Endocrinol (Oxf). 2005;62:738-741.26. Liu E, Meigs JB, Pittas AG, Mc Keown NM, Economos CD, Booth SL, Jacques PF. Plasma 25 hydroxy vitamin D is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr. 2009; 139: 329-334.27. Ford ES, Ajani UA, Mc Guire LC, Luis S. Concentrations of serum Vitamin D and the metabolic syndrome among US adults. Diabetes Care. 2005; 28:1228- 1230.28. Erdönmez D, Hatun S, Çizmecioğlu FM, Keser A. No Relationship Between Vitamin D Status and Insulin Resistance in a Group of High School Students. J Clin Res Pediatr Endocrinol. 2011;3: 198-201.29. Ding L, Wang C, Ma H, Tian Y, Lu Y, Pang S. The Study of Serum Vitamin D and Insulin Resistance in Chinese Populations with Normal Glucose Tolerance. Int J Endocrinol. 2014; 2014:1-4.30. Badawi A, Sayegh S, Sadoun E, Al-Thani M, Arora P, Haddad PS. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2014;7: 297–303.31. Lu L, Yu Z, Pan A, Hu PB, Franco OH, Li H et al. Plasma 25- hyroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care. 2009; 32:1278- 83.32. Chaudhuri JR, Mridula KR, Anamika A. Deficiency of 25-hydroxyvitamin D and dyslipidemia in Indian subjects. J Lipids. 2013; 2013:1-7.33. Zhang MC, Li HX, Liu HM. Serum Vitamin D is Low and Inversely Associated with LDL Cholesterol in the Kazak Ethnic Population: A Cross-Sectional Study. Med Sci Monit. 2014;20:1274–1283.34. Toxqui L, Blanco-Rojo R. Changes in blood pressure and lipid levels in young women consuming a vitamin D-fortified skimmed milk: a randomised controlled trial. Nutrients. 2013;5: 4966–77.35. Saedisomeolia A, Taheri E. Association between serum level of vitamin D and lipid profiles in type 2 diabetic patients in Iran. J Diabetes Metab Disorder. 2014;13:7-11.36. Sollid ST, Hutchinson MYS, Fuskevåg OM, Figenschau Y, Joakimsen RM, Schirmer H et al. No effect of high-dose vitamin d supplementation on glycemic status or cardiovascular risk factors in subjects with prediabetes. Diabetes Care. 2014;37:2123–2131.
Year 2018, Volume: 51 Issue: 2, 90 - 97, 29.08.2018

Abstract

References

  • 1.Holick MF. Vitamin D: a D-lightful health perspective. Nutr Rev. 2008;66: 182-194.2.Lind L, Pollare T, Hvarfner A, Lithell H, Sorensen OH, Ljunghall S. Longterm treatment with active vitamin D (alphacalcidol) in middle-aged men with impaired glucose tolerance. Effects on insulin secretion and sensitivity, glucosetolerance and blood pressure. Diabetes Res. 1989;11:141-147.3.Bischoff-Ferrari H, Giovannucci E, Willett S. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006;84: 18–28.4.Wacker M, Holick MF. Vitamin D-Effects on Skeletal and Extraskeletal Health and the Need for Supplementation. Nutrients 2013;5: 111-148.5.Uçar F, Taşlıpınar MY, Soydaş AÖ, Özcan N. 25-OH vitamin D levels in patients who addmitted to Ankara Etlik Specialized Training Research. Eur J Basic Med Sci. 2012;2: 12-15.6.Bloomgarden ZT. Insulin resistance concepts. Diabetes Care. 2007;30:1320-1326.7.Onat A, Ayhan E, Hergenç G, Can G, Barlan MM. Smoking inhibits visceral fat accumulation in Turkish women: relation of visceral fat and body fat mass to atherogenic dyslipidemia, inflammatory markers, insulin resistance, and blood pressure. Metabolism. 2009;58:963-970.8.Cade C, Norman AW. Rapid normalization/ stimulation by 1,25dihydroxyvitamin D3 of insulin secretion and glucose tolerance in the vitamin D– deficient rat. Endocrinology. 1987;120:1490 –1497.9.Boucher, BJ, Mannan N, Noonan K, Hales CN, Evans SJ. Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia. 1995; 38:1239-124510.Hollick MF, Krane SM. Introduction to Bone and Mineral Metabolism, in Harrison’s Principles of Internal Medicine. 15th ed, McGraw Hill Companies; 2001: p.2198–2201.11.Keskin M, Kurdoğlu S. Homeostasis Model Assessment Is More Reliable Than the Fasting Glucose/Insulin Ratio and Quantitative Insulin Sensitivity Check Index for Assessing Insulin Resistance Among Obese Children and Adolescents. Pediatrıcs. 2005; 115:500-503.12.Holick MF. Vitamin D Deficiency, Medical Progress. The New England Journal Of Medicine. 2007;357: 266–281.13.Song BM, Kim HC, Choi DP, Oh SM, Suh I. Association between Serum 25-Hydroxyvitamin D Level and Insulin Resistance in a Rural Population. Yonsei Med J. 2014;55:1036-1041.14.Olmez D, Bober E, Buyukgebiz A, Cimrin D. The frequency of vitamin D insufficiency in healthy female adolescents. Acta Paediatr. 2006;95:1266-1269.15.Çizmecioglu FM, Etiler N, Görmüş U, Hamzaoglu H, Hatun Ş. Hypovitaminosis D in Obese and Overweight Schoolchildren. J Clin Res Ped Endo. 2008;1:89–96. 16. Cimbek A, Gürsoy G, Kılıç Z, Acar Y, Demirbaş B. Serum hydroxy vitamin D3 levels in type 2 diabetic patients. Med J Ank Hosp. 2012; 45:14-19.17. Evrim N, Atalay E, Gursoy G, Bayram M, Salman RB. Relationship between levels of vitamin D and metabolic syndrome parameters in patients with metabolic syndrome and healthy individuals. Clinics of Turkey J Endocrinol. 2016:11: 36-45. 18. Koshiyama H, Ikeda H, Honjo S, Nakamura Y, Tanaka K, Tsugawa N et al. Hypovitaminosis D is frequent in Japanese subjects with type 2 diabetes. Diabetes Res Clin Pract. 2007;76:470-471.19. Hyppönen E, Power C. Vitamin D status and glucose homeostasis in the 1958 British birth cohort: the role of obesity. Diabetes Care. 2006;29:2244-2246.20.Tahrani AA, Ball A, Shepherd L, Rahim A, Jones AF, Bates A. The prevalence of vitamin D abnormalities in South Asians with type 2 diabetes mellitus in the UK. Int J Clin Pract. 2010;64:351-355.21. Farouhi NG, Ye Z, Rickard AP, Khaw KT, Luben R, Langenberg C et al. Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European prospective investigation into cancer (EPIC)-Norfolk color and updated meta-analysis of prospective studies. Diabetologia. 2012;55:2173–2182. 22. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004;79:820–825. 23. Tsur A, Feldman BS, Feldhammer I, Hoshen MB, Leibowitz G, Balicer RD. Decreased serum concentrations of 25-hydroxycholecalciferol are associated with increased risk of progression to impaired fasting glucose and diabetes. Diabetes Care. 2013;36:1361–1367. 24. Scragg R, Sowers M, Bell C. Serum 25 hydroxy vitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabates Care. 2004; 27:2813-2818. 25. Need AG, O’Loughlin PD, Horowitz M, Nordin BE: Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxy vitamin D in postmenopausal women. Clin Endocrinol (Oxf). 2005;62:738-741.26. Liu E, Meigs JB, Pittas AG, Mc Keown NM, Economos CD, Booth SL, Jacques PF. Plasma 25 hydroxy vitamin D is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr. 2009; 139: 329-334.27. Ford ES, Ajani UA, Mc Guire LC, Luis S. Concentrations of serum Vitamin D and the metabolic syndrome among US adults. Diabetes Care. 2005; 28:1228- 1230.28. Erdönmez D, Hatun S, Çizmecioğlu FM, Keser A. No Relationship Between Vitamin D Status and Insulin Resistance in a Group of High School Students. J Clin Res Pediatr Endocrinol. 2011;3: 198-201.29. Ding L, Wang C, Ma H, Tian Y, Lu Y, Pang S. The Study of Serum Vitamin D and Insulin Resistance in Chinese Populations with Normal Glucose Tolerance. Int J Endocrinol. 2014; 2014:1-4.30. Badawi A, Sayegh S, Sadoun E, Al-Thani M, Arora P, Haddad PS. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2014;7: 297–303.31. Lu L, Yu Z, Pan A, Hu PB, Franco OH, Li H et al. Plasma 25- hyroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care. 2009; 32:1278- 83.32. Chaudhuri JR, Mridula KR, Anamika A. Deficiency of 25-hydroxyvitamin D and dyslipidemia in Indian subjects. J Lipids. 2013; 2013:1-7.33. Zhang MC, Li HX, Liu HM. Serum Vitamin D is Low and Inversely Associated with LDL Cholesterol in the Kazak Ethnic Population: A Cross-Sectional Study. Med Sci Monit. 2014;20:1274–1283.34. Toxqui L, Blanco-Rojo R. Changes in blood pressure and lipid levels in young women consuming a vitamin D-fortified skimmed milk: a randomised controlled trial. Nutrients. 2013;5: 4966–77.35. Saedisomeolia A, Taheri E. Association between serum level of vitamin D and lipid profiles in type 2 diabetic patients in Iran. J Diabetes Metab Disorder. 2014;13:7-11.36. Sollid ST, Hutchinson MYS, Fuskevåg OM, Figenschau Y, Joakimsen RM, Schirmer H et al. No effect of high-dose vitamin d supplementation on glycemic status or cardiovascular risk factors in subjects with prediabetes. Diabetes Care. 2014;37:2123–2131.
There are 1 citations in total.

Details

Primary Language English
Journal Section Original research article
Authors

Gül Gürsoy

Publication Date August 29, 2018
Submission Date October 12, 2018
Published in Issue Year 2018 Volume: 51 Issue: 2

Cite

AMA Gürsoy G. TÜRKİYE’NİN DOĞU BÖLGESİNDE 25-HİDROKSİ VİTAMİN SEVİYESİ İLE DİSLİPİDEMİ VE İNSÜLİN REZİSTASINI ARASINDAKİ İLİŞKİ. Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi. August 2018;51(2):90-97.